Canandaigua National Bank & Trust Co. Purchases 2,079 Shares of HCA Healthcare, Inc. $HCA

Canandaigua National Bank & Trust Co. lifted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 49.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,255 shares of the company’s stock after acquiring an additional 2,079 shares during the quarter. Canandaigua National Bank & Trust Co.’s holdings in HCA Healthcare were worth $2,669,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the business. Sunbelt Securities Inc. raised its stake in shares of HCA Healthcare by 171.7% in the first quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock worth $2,954,000 after acquiring an additional 3,945 shares during the last quarter. Arrowstreet Capital Limited Partnership raised its position in shares of HCA Healthcare by 11.9% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after acquiring an additional 245,887 shares during the last quarter. Sei Investments Co. increased its position in HCA Healthcare by 27.5% in the first quarter. Sei Investments Co. now owns 467,796 shares of the company’s stock worth $221,380,000 after purchasing an additional 100,764 shares during the period. Oddo BHF Asset Management Sas grew its position in shares of HCA Healthcare by 40.8% during the 4th quarter. Oddo BHF Asset Management Sas now owns 9,760 shares of the company’s stock worth $4,557,000 after buying an additional 2,829 shares during the period. Finally, SEB Asset Management AB acquired a new stake in HCA Healthcare during the 1st quarter worth $75,534,000. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Price Performance

NYSE:HCA traded up $6.36 during trading hours on Wednesday, reaching $438.56. 998,798 shares of the stock were exchanged, compared to its average volume of 1,347,548. The firm has a 50 day moving average of $418.32 and a 200 day moving average of $420.54. The stock has a market cap of $94.95 billion, a PE ratio of 14.68, a PEG ratio of 1.47 and a beta of 1.10. HCA Healthcare, Inc. has a twelve month low of $353.99 and a twelve month high of $556.52.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter last year, the firm earned $6.84 earnings per share. Equities research analysts anticipate that HCA Healthcare, Inc. will post 29.42 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th were issued a $0.78 dividend. This represents a $3.12 annualized dividend and a dividend yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 16th. HCA Healthcare’s dividend payout ratio is presently 10.45%.

Analyst Upgrades and Downgrades

A number of research firms recently commented on HCA. Deutsche Bank Aktiengesellschaft set a $476.00 price objective on HCA Healthcare in a report on Monday, July 27th. Barclays lowered their target price on shares of HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating for the company in a research note on Monday, July 27th. Mizuho dropped their price objective on HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 28th. Raymond James Financial set a $528.00 price target on HCA Healthcare in a research report on Tuesday, July 7th. Finally, The Goldman Sachs Group cut their price target on shares of HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a research note on Tuesday, July 28th. Fifteen equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $466.35.

About HCA Healthcare

HCA Healthcare, Inc is a provider of healthcare services in the United States. Through its network of hospitals and other healthcare facilities, the company delivers services including emergency and urgent care, surgery, inpatient and outpatient treatment, women’s and children’s care, cardiology, oncology, orthopedics, and behavioral health services.

HCA Healthcare also operates physician practices, ambulatory surgery centers, freestanding emergency rooms, diagnostic facilities, and other outpatient care sites.